Singular manifolds of proteomic drivers to model the evolution of inflammatory bowel disease status
Ian MorillaiD, Thibaut LégeriD, Assiya Marah, Isabelle Pic, Hatem ZaagiD, Éric Ogier‐DenisiD
Abstract
The conditions who denotes the presence of an immune disease are often represented by interaction graphs. These informative, but complex structures are susceptible to being perturbed at different levels. The mode in which that perturbation occurs is still of utmost importance in areas such as reprogramming therapeutics. In this sense, the overall graph architecture is well characterise by module identification. Topological overlap-related measures make possible the localisation of highly specific module regulators that can perturb other nodes, potentially causing the entire system to change behaviour or collapse. We provide a geometric framework explaining such situations in the context of inflammatory bowel diseases (IBD). IBD are important chronic disorders of the gastrointestinal tract which incidence is dramatically increasing worldwide. Our approach models different IBD status as Riemannian manifolds defined by the graph Laplacian of two high throughput proteome screenings. Identifies module regulators as singularities within the manifolds (the so-called singular manifolds). And reinterprets the characteristic IBD nonlinear dynamics as compensatory responses to perturbations on those singularities. Thus, we could control the evolution of the disease status by reconfiguring particular setups of immune system to an innocuous target state.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.16
- Field percentile
- 42th percentile
- Organism
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NETWORK-BASED FUNCTIONAL FRAGILITY REVEALS SYSTEM-LEVEL REORGANIZATION OF THE GUT MICROBIOME IN INFLAMMATORY BOWEL DISEASE
Mihika Kenavdekar, Elamathi Natarajan·bioRxiv·Apr 21, 2026
- Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel disease
Nguyen Tran Nam Tien, Eun Jeong Choi, … Hong Sub Lee·bioRxiv·May 13, 2024
- Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
R. Kalla, A. T. Adams, … J. Satsangi·bioRxiv·Aug 31, 2020
- Iron Regulatory Protein 1 is Required for the Propagation of Inflammation in Inflammatory Bowel Disease
L. Fahoum, S. Belizowsky, … E. Meyron-Holtz·Journal of Biological ChemistryPeer-reviewed·Sep 1, 2024
- A stromal-state dichotomy governs recalcitrance or remission in inflammatory bowel disease
Courtney Tindle, Harrison M. Penrose, … Pradipta Ghosh·bioRxiv·Jun 13, 2026
- Microbial Immunomodulatory Function is Altered in Inflammatory Bowel Disease Independent of Microbial Composition
Rabina Giri, Jing Jie Teh, … Jakob Begun·bioRxiv·Jul 24, 2026